Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBUPROFEN vs IBUPROFEN LYSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBUPROFEN vs IBUPROFEN LYSINE: Safety Overview

Metric IBUPROFEN IBUPROFEN LYSINE
Total FAERS Reports 87,008 277
Deaths Reported 6,705 27
Death Rate 7.7% 9.7%
Hospitalizations 29,386 110
Average Patient Age 44.0 yrs 12.6 yrs
% Female Patients 60.9% 46.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 13, 2006
Manufacturer Wal-Mart Stores Inc Recordati Rare Diseases Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription